Immune Checkpoint Inhibitor–Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Checkpoint Inhibitor–Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases
Authors
Keywords
-
Journal
ONCOLOGIST
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-08-11
DOI
10.1002/onco.13931
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiac Troponin I and T in Checkpoint Inhibitor–associated Myositis and Myocarditis
- (2021) Edmond Ang et al. JOURNAL OF IMMUNOTHERAPY
- Immune checkpoint inhibitor-associated myasthenia gravis, myositis, and myocarditis overlap syndrome
- (2021) Demis N. Lipe et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Immune Myocarditis Overlapping With Myasthenia Gravis Due to Anti-PD-1 Treatment for a Chordoma Patient: A Case Report and Literature Review
- (2021) Shujing Liang et al. Frontiers in Immunology
- Myositis and myasthenia during nivolumab administration for advanced lung cancer
- (2020) Antonello Veccia et al. ANTI-CANCER DRUGS
- Immunomodulatory Treatment of Immune Checkpoint Inhibitor-Induced Myocarditis: Pathway Toward Precision-Based Therapy
- (2020) Dinu Valentin Balanescu et al. CARDIOVASCULAR PATHOLOGY
- NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020
- (2020) John A. Thompson et al. Journal of the National Comprehensive Cancer Network
- Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
- (2020) Nicolas Palaskas et al. Journal of the American Heart Association
- Nivolumab resulting in persistently elevated troponin levels despite clinical remission of myocarditis and myositis in a patient with malignant pleural mesothelioma: case report
- (2020) Gabrielle Lie et al. Translational Lung Cancer Research
- Myositis-myasthenia gravis overlap syndrome complicated with myasthenia crisis and myocarditis associated with anti-programmed cell death-1 (sintilimab) therapy for lung adenocarcinoma
- (2020) Qian Xing et al. Annals of Translational Medicine
- Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities
- (2020) Yves Allenbach et al. AUTOIMMUNITY REVIEWS
- Fatal association of fulminant myocarditis and rhabdomyolysis after immune checkpoint blockade
- (2020) Raluca Tomoaia et al. EUROPEAN JOURNAL OF CANCER
- Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis
- (2020) Laura Díez-Porras et al. Scientific Reports
- Immune Checkpoint Inhibitor-Induced Myasthenia Gravis
- (2020) Yi-Te Huang et al. Frontiers in Neurology
- A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma
- (2020) Hotaka Matsui et al. International Heart Journal
- Inflammatory myositis in cancer patients receiving immune checkpoint inhibitors
- (2020) Jeffrey Aldrich et al. Arthritis & Rheumatology
- Immune Checkpoint Inhibitor-Induced Myositis: a Case Report and Literature Review
- (2019) Hiroko Kadota et al. Current Rheumatology Reports
- PD-1 inhibitor-associated severe myasthenia gravis with necrotizing myopathy and myocarditis
- (2019) Hayato So et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Myocarditis in the Setting of Cancer Therapeutics
- (2019) Marc P. Bonaca et al. CIRCULATION
- Fatal myocarditis and rhabdomyositis in a patient with stage IV melanoma treated with combined ipilimumab and nivolumab
- (2019) S. D. Saibil et al. Current Oncology
- Diagnosis of immune checkpoint inhibitor-associated myocarditis: A systematic review
- (2019) Richeek Pradhan et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy
- (2019) Khashayar Esfahani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
- (2019) Joe-Elie Salem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review
- (2019) Thomopoulou Konstantina et al. LUNG CANCER
- Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation
- (2019) Rafael Valenti-Azcarate et al. NEUROMUSCULAR DISORDERS
- Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature
- (2019) Houssein Safa et al. Journal for ImmunoTherapy of Cancer
- Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern
- (2019) Ana Matas-García et al. AUTOIMMUNITY REVIEWS
- Late-Onset Fulminant Myocarditis With Immune Checkpoint Inhibitor Nivolumab
- (2018) Shogo Yamaguchi et al. CANADIAN JOURNAL OF CARDIOLOGY
- Severe ophthalmoplegia and myocarditis following the administration of pembrolizumab
- (2018) Fadi Nasr et al. EUROPEAN JOURNAL OF CANCER
- Anti-PD1 associated fulminant myocarditis after a single pembrolizumab dose: the role of occult pre-existing autoimmunity
- (2018) Nicolas Martinez-Calle et al. HAEMATOLOGICA
- PD-1 Inhibitor-associated Myopathies
- (2018) Teerin Liewluck et al. JOURNAL OF IMMUNOTHERAPY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
- (2018) Javid J Moslehi et al. LANCET
- Myositis as an adverse event of immune checkpoint blockade for cancer therapy
- (2018) Mohsin Shah et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Anti-PD1 associated fulminant myocarditis after a single pembrolizumab dose: the role of occult pre-existing autoimmunity
- (2018) Nicolas Martinez-Calle et al. HAEMATOLOGICA
- Presence of antibodies to striated muscle and acetylcholine receptor in association with occurrence of myasthenia gravis with myositis and myocarditis in a patient with melanoma treated with an anti–programmed death 1 antibody
- (2018) T. Shirai et al. EUROPEAN JOURNAL OF CANCER
- Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors
- (2018) Alvaro Moreira et al. EUROPEAN JOURNAL OF CANCER
- Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report
- (2018) Cecilia Monge et al. Journal for ImmunoTherapy of Cancer
- Fulminant Myocarditis Caused by an Immune Checkpoint Inhibitor: A Case Report With Pathologic Findings
- (2018) Ryosuke Imai et al. Journal of Thoracic Oncology
- Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society
- (2016) Nico Melzer et al. JOURNAL OF NEUROLOGY
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- PRISMA harms checklist: improving harms reporting in systematic reviews
- (2016) Liliane Zorzela et al. BMJ-British Medical Journal
- PRISMA harms checklist: improving harms reporting in systematic reviews
- (2016) Liliane Zorzela et al. BMJ-British Medical Journal
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
- (2013) A. L. P. Caforio et al. EUROPEAN HEART JOURNAL
- PD-1 Protects against Inflammation and Myocyte Damage in T Cell-Mediated Myocarditis
- (2012) M. L. Tarrio et al. JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started